Evidence map›Paper›PMID 32885701›Full record

ArticleJournal of the International Association of Providers of AIDS Care

Potential Contributions of Clinical and Community Testing in Identifying Persons with Undiagnosed HIV Infection in the United States.

James G Kahn, Eran Bendavid, Patricia M Dietz, Angela Hutchinson, Hacsi Horvath, Devon McCabe, Richard J Wolitski

Abstract read
In one paragraph

Article in Journal of the International Association of Providers of AIDS Care. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

James G KahnPhilip R. Lee Institute for Health Policy Studies, 8785University of California San Francisco (UCSF) and Consortium to Assess Prevention Economics (CAPE), Berkeley, CA, USA.ORCID 0000-0002-1259-7233
Eran BendavidDivision of General Medical Disciplines, 1242Center for Health Policy and Center for Primary Care and Outcomes Research, Stanford University, Stanford, CA, USA.
Patricia M DietzNational Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP), Centers for Disease Control and Prevention, Atlanta, GA, USA.
Angela HutchinsonNational Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP), Centers for Disease Control and Prevention, Atlanta, GA, USA.
Hacsi HorvathPhilip R. Lee Institute for Health Policy Studies, 8785University of California San Francisco (UCSF) and Consortium to Assess Prevention Economics (CAPE), Berkeley, CA, USA.
Devon McCabePhilip R. Lee Institute for Health Policy Studies, 8785University of California San Francisco (UCSF) and Consortium to Assess Prevention Economics (CAPE), Berkeley, CA, USA.ORCID 0000-0001-8972-8193
Richard J WolitskiNational Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP), Centers for Disease Control and Prevention, Atlanta, GA, USA.

Funding

ECONOMIC ANALYSIS FOR PREVENTION OF DISEASE (EMPoD)U38PS004649 · PS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KAHN, JAMES GUSTAVE · 2014 to 2015
$3.0M
NCHHSTP CDC HHS U38 PS004649
6 · The paper itself

Abstract

backgroundAn estimated 166,155 individuals in the United States have undiagnosed HIV infection. We modeled the numbers of HIV-infected individuals who could be diagnosed in clinical and community settings by broadly implementing HIV screening guidelines.

settingUnited States.

methodsWe modeled testing for general population (once lifetime) and high-risk populations (annual): men who have sex with men, people who inject drugs, and high-risk heterosexuals. We used published data on HIV infections, HIV testing, engagement in clinical care, and risk status disclosure.

resultsIn clinical settings, about 76 million never-tested low-risk and 2.6 million high-risk individuals would be tested, yielding 36,000 and 55,000 HIV diagnoses, respectively. In community settings, 30 million low-risk and 4.4 million high-risk individuals would be tested, yielding 75,000 HIV diagnoses.

conclusionHIV testing in clinical and community settings diagnoses similar numbers of individuals. Lifetime and risk-based testing are both needed to substantially reduce undiagnosed HIV.

Indexed as

AdolescentAdultFemaleHIV InfectionsHIV TestingHomosexuality, MaleHumansMaleMass ScreeningMiddle AgedRisk FactorsSexual and Gender MinoritiesUnited StatesYoung Adultcommunity testingHIVHIV unawaretesting

Identifiers

PMID32885701
PMCPMC7475783

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.